Studies have shown that the PI3K/AKT signaling pathway is abnormally activated in liver cancer, gastric cancer, breast cancer, oral squamous cell carcinoma, and other cancers, and participates in the development and progression of tumors. This evidence concerns the gene AKT1 and gastric cancer.